Note I:   China marketing rights of rheumatoid arthritis and ankylosing spondylitis of LNK01001 were granted to Simcere Pharmaceutical in 2022.
Note II: We granted Bleecker an exclusive, royalty-bearing license to develop, manufacture and commercialize LNK01006 worldwide except Chinese Mainland, Hong Kong, Macau and Taiwan.